Atorvastatin

3-hydroxy-3-methylglutaryl-CoA reductase ; Homo sapiens







125 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34140545 Concomitant attenuation of HMGCR expression and activity enhances the growth inhibitory effect of atorvastatin on TGF-β-treated epithelial cancer cells. 2021 Jun 17 3
2 32523820 Statin-Induced Immune-Mediated Necrotizing Myopathy: An Increasingly Recognized Inflammatory Myopathy. 2020 May 5 1
3 33027917 The Association of 3-Hydroxy-3-Methylglutaryl-CoA Reductase, Apolipoprotein E, and Solute Carrier Organic Anion Genetic Variants with Atorvastatin Response among Jordanian Patients with Type 2 Diabetes. 2020 Oct 5 1
4 31005367 Targeted delivery of atorvastatin via asialoglycoprotein receptor (ASGPR). 2019 Jun 1 1
5 31253872 Neratinib inhibits Hippo/YAP signaling, reduces mutant K-RAS expression, and kills pancreatic and blood cancer cells. 2019 Jul 1
6 31423616 Atorvastatin induces mitochondrial dysfunction and cell apoptosis in HepG2 cells via inhibition of the Nrf2 pathway. 2019 Oct 2
7 31450089 Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: Application in a clinical pharmacokinetic study of single oral dose. 2019 Sep 15 2
8 28802579 Atorvastatin prevents endothelial dysfunction in high glucose condition through Skp2-mediated degradation of FOXO1 and ICAM-1. 2018 Jan 8 1
9 29427701 Statins differentially modulate microRNAs expression in peripheral cells of hyperlipidemic subjects: A pilot study. 2018 May 30 1
10 29615666 Insensitivity to atorvastatin is associated with increased accumulation of intracellular lipid droplets and fatty acid metabolism in breast cancer cells. 2018 Apr 3 1
11 30034619 Concomitant attenuation of HMG-CoA reductase expression potentiates the cancer cell growth-inhibitory effect of statins and expands their efficacy in tumor cells with epithelial characteristics. 2018 Jun 29 2
12 30595323 Randomized controlled trial comparing the efficacy of daily and every other day atorvastatin therapy and its correlation with serum hydroxymethylglutaryl-CoA reductase enzyme levels in naïve dyslipidemic patients. 2018 Dec 1
13 27738832 Effects of Topical Atorvastatin (2 %) on Posthemorrhoidectomy Pain and Wound Healing: A Randomized Double-Blind Placebo-Controlled Clinical Trial. 2017 Feb 1
14 28745862 GlcNAc Conjugated Atorvastatin with Enhanced Water Solubility and Cellular Internalization. 2017 Aug 16 1
15 29065216 Inhibition of Cholesterol Synthesis in HepG2 Cells by GINST-Decreasing HMG-CoA Reductase Expression Via AMP-Activated Protein Kinase. 2017 Nov 1
16 29441875 Influence of SLCO1B1 polymorphisms on atorvastatin efficacy and safety in Macedonian subjects. 2017 May 1 1
17 26408409 HMGCR rs17671591 SNP Determines Lower Plasma LDL-C after Atorvastatin Therapy in Chilean Individuals. 2016 Apr 3
18 26886305 Pharmaceutical Applications of Relaxation Filter-Selective Signal Excitation Methods for ¹⁹F Solid-State Nuclear Magnetic Resonance: Case Study With Atorvastatin in Dosage Formulation. 2016 Mar 2
19 26908399 Varicose Remodeling of Veins Is Suppressed by 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors. 2016 Feb 23 1
20 25591572 Use of atorvastatin in lipid disorders and cardiovascular disease in Chinese patients. 2015 Jan 20 1
21 25668447 Systematic investigation of cellular response and pleiotropic effects in atorvastatin-treated liver cells by MS-based proteomics. 2015 Mar 6 1
22 25745361 PBK/TOPK mediates geranylgeranylation signaling for breast cancer cell proliferation. 2015 2
23 26091578 Expression of OATP2B1 as determinant of drug effects in the microcompartment of the coronary artery. 2015 Sep 1
24 24232833 Chemical and enzymatic approaches to the synthesis of optically pure ethyl (R)-4-cyano-3-hydroxybutanoate. 2014 Jan 2
25 24233489 Inflammatory stress induces statin resistance by disrupting 3-hydroxy-3-methylglutaryl-CoA reductase feedback regulation. 2014 Feb 2
26 24575888 Asymmetric synthesis of the HMG-CoA reductase inhibitor atorvastatin calcium: an organocatalytic anhydride desymmetrization and cyanide-free side chain elongation approach. 2014 Mar 21 1
27 24783072 Alternate Day versus Once Daily Atorvastatin for Primary Prevention of (CHD) in Naïve Patients of Dyslipidemia. 2014 Mar 1
28 24895437 Inflammatory stress reduces the effectiveness of statins in the kidney by disrupting HMGCoA reductase feedback regulation. 2014 Oct 3
29 24932497 Stimulatory interactions between human coronary smooth muscle cells and dendritic cells. 2014 1
30 25013913 Modulation of dendritic cell immunobiology via inhibition of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase. 2014 1
31 25022881 Molecular modeling studies of atorvastatin analogues as HMGR inhibitors using 3D-QSAR, molecular docking and molecular dynamics simulations. 2014 Aug 15 1
32 25311809 Inhibition of protein geranylgeranylation specifically interferes with CD40-dependent B cell activation, resulting in a reduced capacity to induce T cell immunity. 2014 Nov 15 1
33 23471651 Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial. 2013 Apr 2
34 24177008 Atorvastatin inhibited Rho-associated kinase 1 (ROCK1) and focal adhesion kinase (FAK) mediated adhesion and differentiation of CD133+CD44+ prostate cancer stem cells. 2013 Nov 22 1
35 21427285 Effect of HMGCR variant alleles on low-density lipoprotein cholesterol-lowering response to atorvastatin in healthy Korean subjects. 2012 Mar 3
36 22108629 Rationale and design of a trial on the effect of high dose statins on cardiovascular risk in adults after successful coarctation repair. 2012 Mar 1
37 22177940 Explication of interactions between HMGCR isoform 2 and various statins through In silico modeling and docking. 2012 Feb 1
38 22569288 Comparison of alternate-day atorvastatin treatment to daily treatment in maintaining LDL-cholesterol targets in patients with variable coronary risk profile. 2012 May 1
39 22989091 A novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) splice variant with an alternative exon 1 potentially encoding an extended N-terminus. 2012 Sep 18 2
40 23525139 ChemVassa: A New Method for Identifying Small Molecule Hits in Drug Discovery. 2012 1
41 21083855 Effects of high-dose statin on the human hepatic expression of genes involved in carbohydrate and triglyceride metabolism. 2011 Mar 1
42 21123766 Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men. 2011 Mar 3
43 21871913 Antinociception induced by atorvastatin in different pain models. 2011 Nov 1
44 19930424 Atorvastatin increases expression of low-density lipoprotein receptor mRNA in human circulating mononuclear cells. 2010 Apr 1
45 20108992 Amlodipine/Atorvastatin: a review of its use in the treatment of hypertension and dyslipidaemia and the prevention of cardiovascular disease. 2010 2
46 20177788 Combined hyperlipidemia in patients with lysinuric protein intolerance. 2010 Dec 1
47 20387911 Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study. 2010 1
48 20578904 Common variants of HMGCR, CETP, APOAI, ABCB1, CYP3A4, and CYP7A1 genes as predictors of lipid-lowering response to atorvastatin therapy. 2010 Oct 2
49 20653359 Effects of lipid-lowering therapy on reduction of cardiovascular events in patients with end-stage renal disease requiring hemodialysis. 2010 Aug 1
50 20678686 Pharmacokinetics and bioequivalence evaluation of two different atorvastatin calcium 10-mg tablets: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy fasted Chinese adult males. 2010 Jul 1